Open access · OA
via OpenAlex
Application of a C. elegans Dopamine Neuron Degeneration Assay for the Validation of Potential Parkinson's Disease Genes
Laura A. Berkowitz, Shusei Hamamichi, Adam L. Knight, Adam J. Harrington, Guy A. Caldwell, Kim A. Caldwell
Journal of Visualized Experiments · 2008 · ▲ 49 citations
Abstract
Improvements to the diagnosis and treatment of Parkinson's disease (PD) are dependent upon knowledge about susceptibility factors that render populations at risk. In the process of attempting to identify novel genetic factors associated with PD, scientists have generated many lists of candidate genes, polymorphisms, and proteins that represent important advances, but these leads remain mechanistically undefined. Our work is aimed toward significantly narrowing such lists by exploiting the advantages of a simple animal model system. While humans have billions of neurons, the microscopic roundworm Caenorhabditis elegans has precisely 302, of which only eight produce dopamine (DA) in hemaphrodites. Expression of a human gene encoding the PD-associated protein, alpha-synuclein, in C. elegans DA neurons results in dosage and age-dependent neurodegeneration. Worms expressing human alpha-synuclein in DA neurons are isogenic and express both GFP and human alpha-synuclein under the DA transporter promoter (Pdat-1). The presence of GFP serves as a readily visualized marker for following DA neurodegeneration in these animals. We initially demonstrated that alpha-synuclein-induced DA neurodegeneration could be rescued in these animals by torsinA, a protein with molecular chaperone activity. Further, candidate PD-related genes identified in our lab via large-scale RNAi screening efforts using an alpha-synuclein misfolding assay were then over-expressed in C. elegans DA neurons. We determined that five of seven genes tested represented significant candidate modulators of PD as they rescued alpha-synuclein-induced DA neurodegeneration. Additionally, the Lindquist Lab (this issue of JoVE) has performed yeast screens whereby alpha-synuclein-dependent toxicity is used as a readout for genes that can enhance or suppress cytotoxicity. We subsequently examined the yeast candidate genes in our C. elegans alpha-synuclein-induced neurodegeneration assay and successfully validated many of these targets. Our methodology involves generation of a C. elegans DA neuron-specific expression vector using recombinational cloning of candidate gene cDNAs under control of the Pdat-1 promoter. These plasmids are then microinjected in wild-type (N2) worms, along with a selectable marker for successful transformation. Multiple stable transgenic lines producing the candidate protein in DA neurons are obtained and then independently crossed into the alpha-synuclein degenerative strain and assessed for neurodegeneration, at both the animal and individual neuron level, over the course of aging.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.3791/835
- Canonical
- link ↗
- Fetched
- 2026-10-21 MST
Cite this
APA
Berkowitz, L.A., Hamamichi, S., Knight, A.L., Harrington, A.J., Caldwell, G.A., & Caldwell, K.A. (2008). Application of a C. elegans Dopamine Neuron Degeneration Assay for the Validation of Potential Parkinson's Disease Genes. <em>Journal of Visualized Experiments</em>. https://doi.org/10.3791/835
Vancouver
Berkowitz LA, Hamamichi S, Knight AL, Harrington AJ, Caldwell GA, Caldwell KA. Application of a C. elegans Dopamine Neuron Degeneration Assay for the Validation of Potential Parkinson's Disease Genes. Journal of Visualized Experiments. 2008. doi:10.3791/835.
BibTeX
@article{laura2008Applic,
title = {Application of a C. elegans Dopamine Neuron Degeneration Assay for the Validation of Potential Parkinson's Disease Genes},
author = {Laura A. Berkowitz and Shusei Hamamichi and Adam L. Knight and Adam J. Harrington and Guy A. Caldwell and Kim A. Caldwell},
journal = {Journal of Visualized Experiments},
year = {2008},
doi = {10.3791/835},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Proceedings of the National Academy of Sciences 2008
Preprint · OA
Hypothesis-based RNAi screening identifies neuroprotective genes in a Parkinson's disease model
Aktuelle Neurologie 2005
Citation only
Conditional control of human wildtype and mutated [A30P] alpha-synuclein in a mouse model of Parkinson's disease
Genome Research 2005
Preprint · OA
Analysis of long-lived C. elegans daf-2 mutants using serial analysis of gene expression
Progress in Lipid Research 2010
Citation only
Alpha-synuclein, lipids and Parkinson’s disease
2026
Citation only
Parkinson’s Disease
Aging Cell 2014
Open access · CC-BY